Search Results for "treatment-persistence"
-
Adimadhyam S
,
Lewis JD
,
Simon AL
et al
.
Real-world evidence comparing tofacitinib and vedolizumab in anti-TNF-experienced patients with ulcerative colitis
.Inflamm Bowel Dis.
2024;
30
(4)
: 554-62
. doi: 10.1093/ibd/izad115
.
-
Horton DB
,
Yang Y
,
Neikirk AL
et al
.
Impact of the COVID-19 pandemic on the management of juvenile idiopathic arthritis: analysis of United States commercial insurance data
.J Clin Rheumatol.
2023;
29
(8)
: 388-95
. doi: 10.1097/RHU.0000000000002035
.
-
Kappelman MD
,
Lewis JD
,
Zhang X
et al
.
Comparing patient-reported outcomes among anti-TNF-experienced patients with crohn's disease initiating vedolizumab versus ustekinumab
.Dig Dis Sci.
2023;
68
(8)
: 3413-20
. doi: 10.1007/s10620-023-07942-0
.
-
Kappelman MD
,
Long MD
,
Zhang X
et al
.
Comparing patient-reported outcomes among anti-TNF experienced patients with ulcerative colitis initiating vedolizumab versus tofacitinib
.Crohns Colitis 360.
2023;
5
(3)
: otad031
. doi: 10.1093/crocol/otad031
.
-
Kappelman MD
,
Adimadhyam S
,
Hou L
et al
.
Real-world evidence comparing vedolizumab and ustekinumab in antitumor necrosis factor-experienced patients with crohn's disease
.Am J Gastroenterol.
2023;
118
(4)
: 674-84
. doi: 10.14309/ajg.0000000000002068
.